Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention.

Brink A, Coetzee J, Clay C, Corcoran C, van Greune J, Deetlefs JD, Nutt L, Feldman C, Richards G, Nordmann P, Poirel L.

S Afr Med J. 2012 May 10;102(7):599-601.

PMID:
22748433
2.

Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.

Guh AY, Limbago BM, Kallen AJ.

Expert Rev Anti Infect Ther. 2014 May;12(5):565-80. doi: 10.1586/14787210.2014.902306. Epub 2014 Mar 25. Review.

PMID:
24666262
3.

Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?

Yamamoto M, Pop-Vicas AE.

Crit Care. 2014 Jun 27;18(3):229. doi: 10.1186/cc13949. Review.

4.

Carbapenem-resistant enterobacteriaceae: an emerging problem in children.

Logan LK.

Clin Infect Dis. 2012 Sep;55(6):852-9. doi: 10.1093/cid/cis543. Epub 2012 Jun 14. Review.

PMID:
22700827
5.

An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.

Schwaber MJ, Carmeli Y.

Clin Infect Dis. 2014 Mar;58(5):697-703. doi: 10.1093/cid/cit795. Epub 2013 Dec 4. Review. Erratum in: Clin Infect Dis. 2014 Jul 15;59(2):323.

PMID:
24304707
6.

Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae.

Martirosov DM, Lodise TP.

Diagn Microbiol Infect Dis. 2016 Jun;85(2):266-75. doi: 10.1016/j.diagmicrobio.2015.10.008. Epub 2015 Oct 14. Review.

PMID:
27033631
7.

Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).

Goodman KE, Simner PJ, Tamma PD, Milstone AM.

Expert Rev Anti Infect Ther. 2016;14(1):95-108. doi: 10.1586/14787210.2016.1106940. Epub 2015 Nov 4. Review.

PMID:
26535959
8.

Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients.

Perez F, Van Duin D.

Cleve Clin J Med. 2013 Apr;80(4):225-33. doi: 10.3949/ccjm.80a.12182. Review.

9.

Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose.

Savard P, Perl TM.

Clin Microbiol Infect. 2014 Sep;20(9):854-61. doi: 10.1111/1469-0691.12748. Epub 2014 Aug 11. Review.

10.

Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae.

Munoz-Price LS, Quinn JP.

Curr Opin Infect Dis. 2013 Aug;26(4):378-87. doi: 10.1097/01.qco.0000431853.71500.77. Review.

PMID:
23806900
11.

Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.

Temkin E, Adler A, Lerner A, Carmeli Y.

Ann N Y Acad Sci. 2014 Sep;1323:22-42. doi: 10.1111/nyas.12537. Review.

PMID:
25195939
12.

Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

Gupta N, Limbago BM, Patel JB, Kallen AJ.

Clin Infect Dis. 2011 Jul 1;53(1):60-7. doi: 10.1093/cid/cir202. Review.

PMID:
21653305
13.

The role of antimicrobial stewardship in curbing carbapenem resistance.

Bogan C, Marchaim D.

Future Microbiol. 2013 Aug;8(8):979-91. doi: 10.2217/fmb.13.73. Review.

PMID:
23902145
14.

[Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues].

Lepelletier D, Batard E, Berthelot P, Zahar JR, Lucet JC, Fournier S, Jarlier V, Grandbastien B.

Rev Med Interne. 2015 Jul;36(7):474-9. doi: 10.1016/j.revmed.2014.12.006. Epub 2015 Jan 15. Review. French.

PMID:
25600328
15.

Combination therapy for carbapenem-resistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions.

Nabarro LE, Veeraraghavan B.

Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2307-11. doi: 10.1007/s10096-015-2486-7. Epub 2015 Sep 12. Review.

PMID:
26363636
16.

Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?

Perez F, El Chakhtoura NG, Papp-Wallace KM, Wilson BM, Bonomo RA.

Expert Opin Pharmacother. 2016;17(6):761-81. doi: 10.1517/14656566.2016.1145658. Epub 2016 Mar 9. Review.

17.

Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii: assessing their impact on organ transplantation.

Patel G, Perez F, Bonomo RA.

Curr Opin Organ Transplant. 2010 Dec;15(6):676-82. doi: 10.1097/MOT.0b013e3283404373. Review.

PMID:
20930636
18.

A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings.

Savard P, Perl TM.

Curr Opin Infect Dis. 2012 Aug;25(4):371-7. doi: 10.1097/QCO.0b013e3283558c17. Review.

PMID:
22766646
19.

Carbapenem-resistant enterobacteriaceae: occult threat in the intensive care unit.

Zurawski RM.

Crit Care Nurse. 2014 Oct;34(5):44-52. doi: 10.4037/ccn2014602. Review.

20.

Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae.

Gazin M, Paasch F, Goossens H, Malhotra-Kumar S; MOSAR WP2 and SATURN WP1 Study Teams.

J Clin Microbiol. 2012 Apr;50(4):1140-6. doi: 10.1128/JCM.06852-11. Epub 2012 Jan 18. Review.

Supplemental Content

Support Center